NCT05758701View on ClinicalTrials.gov

CT TAVR Abdomen Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions
Transcatheter Aortic Valve Replacement
Interventions
COMBINATION_PRODUCT

Iodinated Contrast Agent (Omnipaque)

Standard dosage of Omnipaque for CT imaging is 100 ml. Cohort will be given a reduced dosage.

DEVICE

Dual Energy CT

Dual energy CT scanners enable monoenergetic CT image reconstruction which allows for improved iodine image contrast.

Trial Locations (1)

21201

RECRUITING

University of Maryland Medical Center, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER